These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

432 related items for PubMed ID: 25257194

  • 1. Hyperhemolysis syndrome in a patient without a hemoglobinopathy, unresponsive to treatment with eculizumab.
    Gupta S, Fenves A, Nance ST, Sykes DB, Dzik WS.
    Transfusion; 2015 Mar; 55(3):623-8. PubMed ID: 25257194
    [Abstract] [Full Text] [Related]

  • 2. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.
    Talano JA, Hillery CA, Gottschall JL, Baylerian DM, Scott JP.
    Pediatrics; 2003 Jun; 111(6 Pt 1):e661-5. PubMed ID: 12777582
    [Abstract] [Full Text] [Related]

  • 3. Anti-N and anti-Doa immunoglobulin G alloantibody-mediated delayed hemolytic transfusion reaction with hyperhemolysis in sickle cell disease treated with eculizumab and HBOC-201: case report and review of the literature.
    Unnikrishnan A, Pelletier JPR, Bari S, Zumberg M, Shahmohamadi A, Spiess BD, Michael MJ, Harris N, Harrell D, Mandernach MW.
    Transfusion; 2019 Jun; 59(6):1907-1910. PubMed ID: 30768787
    [Abstract] [Full Text] [Related]

  • 4. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions.
    Aygun B, Padmanabhan S, Paley C, Chandrasekaran V.
    Transfusion; 2002 Jan; 42(1):37-43. PubMed ID: 11896310
    [Abstract] [Full Text] [Related]

  • 5. Challenges in preventing and treating hemolytic complications associated with red blood cell transfusion.
    Chonat S, Arthur CM, Zerra PE, Maier CL, Jajosky RP, Yee MEM, Miller MJ, Josephson CD, Roback JD, Fasano R, Stowell SR.
    Transfus Clin Biol; 2019 May; 26(2):130-134. PubMed ID: 30979566
    [Abstract] [Full Text] [Related]

  • 6. Successful Outcome of Hyperhemolysis in Sickle Cell Disease following Multiple Lines of Treatment: The Role of Complement Inhibition.
    Vlachaki E, Gavriilaki E, Kafantari K, Adamidou D, Tsitsikas D, Chasapopoulou E, Anagnostopoulos A, Tsapas A.
    Hemoglobin; 2018 May; 42(5-6):339-341. PubMed ID: 30626228
    [Abstract] [Full Text] [Related]

  • 7. Successful treatment of recurrent hyperhemolysis syndrome with immunosuppression and plasma-to-red blood cell exchange transfusion.
    Uhlmann EJ, Shenoy S, Goodnough LT.
    Transfusion; 2014 Feb; 54(2):384-8. PubMed ID: 23692505
    [Abstract] [Full Text] [Related]

  • 8. Successful use of eculizumab for treatment of an acute hemolytic reaction after ABO-incompatible red blood cell transfusion.
    Weinstock C, Möhle R, Dorn C, Weisel K, Höchsmann B, Schrezenmeier H, Kanz L.
    Transfusion; 2015 Mar; 55(3):605-10. PubMed ID: 25251967
    [Abstract] [Full Text] [Related]

  • 9. Hyperhemolysis syndrome in anemia of chronic disease.
    Darabi K, Dzik S.
    Transfusion; 2005 Dec; 45(12):1930-3. PubMed ID: 16371046
    [Abstract] [Full Text] [Related]

  • 10. Posttransfusion hyperhemolysis is arrested by targeting macrophage activation with novel use of Tocilizumab.
    Lee LE, Beeler BW, Graham BC, Cap AP, Win N, Chen F.
    Transfusion; 2020 Jan; 60(1):30-35. PubMed ID: 31642065
    [Abstract] [Full Text] [Related]

  • 11. Immuno-hematological findings in Delayed Hemolytic Transfusion Reaction (DHTR).
    Thonier V.
    Transfus Clin Biol; 2019 May; 26(2):102-108. PubMed ID: 30885514
    [Abstract] [Full Text] [Related]

  • 12. Management of delayed hemolytic transfusion reaction in sickle cell disease: Prevention, diagnosis, treatment.
    Pirenne F, Bartolucci P, Habibi A.
    Transfus Clin Biol; 2017 Sep; 24(3):227-231. PubMed ID: 28669521
    [Abstract] [Full Text] [Related]

  • 13. Delayed Severe Hemolytic Transfusion Reaction During Pregnancy in a Woman with β-Thalassemia Intermediate: Successful Outcome After Eculizumab Administration.
    Cannas G, Dubreuil L, Fichez A, Gerfaud-Valentin M, Debard AL, Hot A.
    Am J Case Rep; 2021 May 13; 22():e931107. PubMed ID: 33983909
    [Abstract] [Full Text] [Related]

  • 14. Delayed hemolytic transfusion reaction with hyperhemolysis after first red blood cell transfusion in child with beta-thalassemia: challenges in treatment.
    Hannema SE, Brand A, van Meurs A, Smiers FJ.
    Transfusion; 2010 Feb 13; 50(2):429-32. PubMed ID: 19788508
    [Abstract] [Full Text] [Related]

  • 15. An Unusual Case of Delayed Hemolytic Transfusion Reaction With Hyperhemolysis Syndrome Due to Anti-Jkb and Anti-Fya Alloantibodies.
    El Alaoui K, Benghiat FS, Colard M.
    J Hematol; 2022 Apr 13; 11(2):66-70. PubMed ID: 35573755
    [Abstract] [Full Text] [Related]

  • 16. Clinical presentation of delayed hemolytic transfusion reactions and hyperhemolysis in sickle cell disease.
    Fasano RM, Miller MJ, Chonat S, Stowell SR.
    Transfus Clin Biol; 2019 May 13; 26(2):94-98. PubMed ID: 30837199
    [Abstract] [Full Text] [Related]

  • 17. Anti-HI can cause a severe delayed hemolytic transfusion reaction with hyperhemolysis in sickle cell disease patients.
    Ibanez C, Habibi A, Mekontso-Dessap A, Chadebech P, Chami B, Bierling P, Galactéros F, Rieux C, Nataf J, Bartolucci P, Peyrard T, Pirenne F.
    Transfusion; 2016 Jul 13; 56(7):1828-33. PubMed ID: 27145018
    [Abstract] [Full Text] [Related]

  • 18. A delayed hemolytic transfusion reaction (DHTR) with multiple alloantibodies (Anti-E, Jka, Dia, Fyb, and S) induced by E-antigen-negative, crossmatch-compatible blood.
    Yamane K, Yagihashi A, Sasaki M, Kuwashima K, Morio A, Watanabe N.
    Immunopharmacol Immunotoxicol; 1998 Nov 13; 20(4):531-9. PubMed ID: 9805232
    [Abstract] [Full Text] [Related]

  • 19. Difficulties in identifying antibodies in the Dombrock blood group system in multiply alloimmunized patients.
    Strupp A, Cash K, Uehlinger J.
    Transfusion; 1998 Nov 13; 38(11-12):1022-5. PubMed ID: 9838931
    [Abstract] [Full Text] [Related]

  • 20. Red blood cell alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease.
    Balbuena-Merle R, Hendrickson JE.
    Transfus Clin Biol; 2019 May 13; 26(2):112-115. PubMed ID: 30857806
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.